PT  - JOURNAL ARTICLE
AU  - Du, Zhanwei
AU  - Wang, Lin
AU  - Yang, Bingyi
AU  - Ali, Sheikh Taslim
AU  - Tsang, Tim K.
AU  - Shan, Songwei
AU  - Wu, Peng
AU  - Lau, Eric H. Y.
AU  - Cowling, Benjamin J.
AU  - Meyers, Lauren Ancel
TI  - International risk of the new variant COVID-19 importations originating in the United Kingdom
AID  - 10.1101/2021.01.09.21249384
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.09.21249384
4099  - http://medrxiv.org/content/early/2021/02/21/2021.01.09.21249384.short
4100  - http://medrxiv.org/content/early/2021/02/21/2021.01.09.21249384.full
AB  - A fast-spreading SARS-CoV-2 variant identified in the United Kingdom in December 2020 has raised international alarm. We estimate that, in 16 out of 19 countries analyzed, there is at least a 50% chance the variant was imported by travelers from the United Kingdom by December 7th.Article Summary Line The new variant COVID-19 has likely been introduced by travelers from the UK and spreading undetected for months in many countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFinancial support was provided by the Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (grant no. COVID190118), the US National Institutes of Health (grant no. R01 AI151176) and CDC COVID Supplement (grant no. U01IP001136).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not appliableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot applicable